Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
3.000
-0.170 (-5.36%)
At close: Apr 13, 2026, 4:00 PM EDT
3.000
0.00 (0.00%)
After-hours: Apr 13, 2026, 4:00 PM EDT
IMDX Employees
As of December 31, 2025, Insight Molecular Diagnostics had 58 total employees, including 55 full-time and 3 part-time employees. The number of employees increased by 9 or 18.37% compared to the previous year.
Employees
58
Change (1Y)
9
Growth (1Y)
18.37%
Revenue / Employee
$69,914
Profits / Employee
-$865,897
Market Cap
96.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 58 | 9 | 18.37% | 55 | 3 |
| Dec 31, 2024 | 49 | 3 | 6.52% | 46 | 3 |
| Dec 31, 2023 | 46 | -30 | -39.47% | 43 | 3 |
| Dec 31, 2022 | 76 | -39 | -33.91% | 75 | 1 |
| Dec 31, 2021 | 115 | 64 | 125.49% | 110 | 5 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 883 |
| Burning Rock Biotech | 674 |
| FONAR | 535 |
| Biodesix | 334 |
| MDxHealth | 312 |
| Prenetics Global | 285 |
IMDX News
- 18 days ago - IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results - GlobeNewsWire
- 24 days ago - iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Second Study Affirms Superiority of iMDx GraftAssure Assay's Proprietary dd-cfDNA Combination Model Score - GlobeNewsWire
- 5 weeks ago - Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission - GlobeNewsWire
- 2 months ago - iMDx Announces $26.0 Million Registered Direct Offering - GlobeNewsWire
- 3 months ago - IMDX Supports AST and ASHI STAR Working Group's Call for Decentralized Transplant Monitoring - GlobeNewsWire
- 3 months ago - iMDx Announces “JPM Week” and “BTIG Snowbird” Conference Participation - GlobeNewsWire
- 3 months ago - iMDx to Welcome Industry Veteran as Vice President of Medical Affairs to Prepare for Commercial Transplant Assay Launch - GlobeNewsWire